STSS Sharps Technology Inc: רווח למניה ב-12 החודשים האחרונים

Sharps Technology, Inc. (STSS) aims for dominance in the advanced drug delivery systems segment by implementing safety syringes to eliminate reuse. The EPS (TTM) price trend is currently at 99.30. The business relies on stable demand within the medical sector, although the product go-to-market stage impacts financial stability. Human capital is provided by experienced engineers and FDA standards experts.

Sharps Technology, Inc. (STSS) possesses significant pricing power within the safe drug delivery systems segment, which translates directly into earnings per share efficiency. This indicator is calculated as the percentage change in net income over the last 12 months relative to the same period last year. The metric objectifies the business's profitability trends, allowing investors to filter out market noise and assess the real pace of capital growth. By analyzing the historical percentage growth of EPS YoY (TTM), one can determine the company's development phase and avoid purchasing the asset at a local maximum.